ArticleBMJ open2026

Hemopurifier device in patients with solid tumours who have stable or progressive disease while on a treatment that includes pembrolizumab or nivolumab: protocol for an Australian safety, feasibility and dose-finding study.

Michael P Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.